Home » Pharmaceutical Project Management
Product Image

Pharmaceutical Project Management

€235.60
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
Al Sa
Category=KND
chemistry manufacturing control
Clinical Candidate Development
clinical trial management
CMC Activity
companies
company
contract
critical
Cycle Time
Da Ta
Data
development
drug
drug development process
Drug Substance
eq_bestseller
eq_business-finance-law
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
Functional Service Provider
Group PM.
Ich E8
large
MAA
National MOH
path
Patients Undergoing Knee Surgery
Pharma Companies
pharmaceutical lifecycle project planning
Pharmaceutical Project Manager
Portfolio Management
Portfolio Management Process
portfolio risk assessment
Pr Ep
RA Department
RA Management
RA Professional
regulatory affairs strategies
research
St Ep
Structureactivity Relationship
Ta Ge
Te Ch
team
team leadership skills

Product details

  • ISBN 9780849340246
  • Weight: 680g
  • Dimensions: 152 x 229mm
  • Publication Date: 17 Mar 2008
  • Publisher: Taylor & Francis Inc
  • Publication City/Country: US
  • Product Form: Hardback
Secure checkout Fast Shipping Easy returns
Description

Encompassing the full spectrum of project management’s role and responsibility encountered in the pharmaceutical industry, Pharmaceutical Project Management outlines the key objectives, risks, and challenges of each stage of the pharmaceutical lifecycle, from discovery and preclinical phases through clinical development, manufacturing, registration, and launch.

New updated material includes:

  • expert recommendations and informative articles on decision-making
  • planning principles and planning systems
  • management of subcontracted development
  • manufacturing project management
  • team leadership and skill sets
  • drug development strategies

It covers primary project management objectives, functions, and descriptions of the nature and execution of work activities in a clear and reader-friendly format to illustrate key characteristics and objectives, assist managers in projecting the risks and challenges of each development option, and supply concise recommendations for successful project planning.
About

Tony Kenedy is Vice President of Development at Trigen, Ltd in London, U.K. Dr. Kennedy, a Medical Research Council Postdoctoral Research Fellow at The School of Pharmacy, London University, U.K., was awarded his Ph.D. by London University, U.K. and was previously the Global Head of Project Management at Roche, Switzerland. He was the editor of the first edition of Pharmaceutical Project Management which was published by Marcel Dekker in 1998, and his career has been devoted to the discovery and development of novel drugs while working in large pharmaceutical and small biotech companies. Dr. Kennedy has directed global drug development teams in several therapeutic areas including cardiovascular, gastrointestinal, infectious disease, rheumatology and oncology, and led the Roche-Gilead joint development team that took the flu antiviral Tamiflu to registration three years after the discovery of the molecule.